Review
Open access
Aug 2026
CRISPR-Cas systems as precision antimicrobials: Reversing the tide of antimicrobial resistance
In vivo models confirm significant reduction of resistant pathogens, supporting clinical translational potential and key challenges remain in off-target effects, manufacturing, and regulatory approval for human use.
Mahsa Khosrojerdi, S. Hashemi, Reza Besharati et al.
· Virus Research · 0 citations